BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€98.83
Performance (%)
-9.70%
Price
09.05.24
€76.16
Summary
This prediction is currently active. With a performance of -9.70%, the BUY prediction for BioMarin Pharmaceutical Inc. by Piper_Sandler is down slightly. This prediction currently runs until 23.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -0.600% | -0.600% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat